Absynth Biologics
Sheffield · Founded 2007
About Absynth Biologics
Absynth Biologics has been created with the initial goal of developing immunological prophylaxis and therapy to combat bacterial infections. Absynth’s strategy is to exploit the characterisation of carefully selected novel proteins Staphylococcus aureus (S. aureus)in bacteria as immunological targets.
Company Facts
- Founded: 2007
- Legal name: Absynth Biologics Limited
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $1.7M
- Last round: Equity Crowdfunding (Sep 2017)
- Website: absynthbiologics.co.uk
- Phone: (151) 482-9155
Social Profiles
Canonical: https://fsome.com/organization/absynth-biologics-8293525 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.